Categories Earnings, Retail

Pinduoduo (PDD) earnings preview: Strong user base to benefit Q3 results

Pinduoduo Inc. (NASDAQ: PDD) is slated to report third quarter 2019 earnings results on Wednesday, November 20, before the market opens. Analysts expect the company to report a loss of $0.08 per share on revenue of $1.05 billion.

The increases in monthly active users and active buyers as well as the spending per active buyer are expected to drive revenue growth in the third quarter. Last quarter, all three metrics saw double-digit growth compared to the year-ago period.

Gross merchandise volume (GMV), which measures the total value of all orders placed on the platform, is another important metric to note. Last quarter, GMV increased 171% from the previous year. Last month, Pinduoduo’s founder and chairman Colin Huang said the company’s GMV has surpassed that of competitor JD.com (NASDAQ: JD), although the actual numbers were not disclosed.

Also read: JD.com Q3 2019 Earnings Report

Pinduoduo’s low-price business model is another advantage that will help fuel growth. Although the company is still delivering losses, analysts estimate Pinduoduo will achieve profitability in 2020. Last month, the stock gained significantly on reports that the trade tensions between the US and China were slowly easing.

In the second quarter of 2019, Pinduoduo reported an increase in revenue and a narrower-than-expected loss. Revenues jumped 169% to $1.062 billion while adjusted loss was $0.04 per share. Average monthly active users increased 88%.

Pinduoduo’s shares have gained 91% year-to-date and 30% in the past one month. The majority of analysts have rated the stock as Buy and the average price target is $39.62.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Walgreens Boots Alliance set to report earnings next week. Here’s what to expect

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the drug store chain that is expanding into a diversified healthcare provider, is on a restructuring drive aimed at better aligning the business with

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top